Construction and characterization of an anti-CD20 mAb nanocomb with exceptionally excellent lymphoma-suppressing activity
Hua-Fei Li,1–3,* Cong Wu,4,* Ting Chen,5,* Ge Zhang,1 He Zhao,1 Chang-Hong Ke,1 Zheng Xu21International Joint Cancer Institute, Translation Medicine Institute, 2Planning Division, Scientific Research Department, 3Tumor Immunology and Gene Therapy Center, Eastern Hepatobiliary Surgery Hospi...
Guardado en:
Autores principales: | Li H, Wu C, Chen T, Zhang G, Zhao H, Ke C, Xu Z |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/945480114bc1414b81e77681651ed775 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
B cell depletion with anti-CD20 mAb exacerbates anti-donor CD4+ T cell responses in highly sensitized transplant recipients
por: Asuka Tanaka, et al.
Publicado: (2021) -
Daunorubicin-Loaded CdTe QDs Conjugated with Anti-CD123 mAbs: A Novel Delivery System for Myelodysplastic Syndromes Treatment
por: Guo D, et al.
Publicado: (2020) -
Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2
por: Margherita Passariello, et al.
Publicado: (2021) -
Endothelial eNAMPT drives EndMT and preclinical PH: rescue by an eNAMPT-neutralizing mAb
por: Mohamed Ahmed, et al.
Publicado: (2021) -
Generation of a canine anti-canine CD20 antibody for canine lymphoma treatment
por: Takuya Mizuno, et al.
Publicado: (2020)